Mood disorders and psychosis in HIV

HIV and Psychiatry: Training and Resource Manual, Second Edition

Volumn , Issue , 2005, Pages 88-109

  Stolar, Andrea ^a   Catalano, Glenn ^a   Hakala, Sheryl M ^a   Bright, Robert P ^b   Fernandez, Francisco ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927068146     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511543586.005     Document Type: Chapter

References (70)

1. Akula, S. K., Rege, A. B., Dreisbach, A.W. et al. Valproic acid increases cerebrospinal fluid zidovudine levels in a patient with AIDS. American Journal of Medicine and Science, 313 (1997): 244-6.
2. Alciati, A., Fusi, A., D'Arminio Monforte, A. et al. New-onset delusions and hallucinations in patients infected with HIV. Journal of Psychiatry and Neuroscience, 26(3) (2001b): 229-34.
3. Alciati, A., Starace, F., Scaramelli, B. et al. Has there been a decrease in the prevalence of mood disorders in HIV-seropositive individuals since the introduction of combination therapy? European Psychiatry, 16(8) (2001a): 491-6.
4. Andersson, E., Hansson, I. and Norlin, K. Depression caused by herpes simplex encephalitis. Atypical symptoms were misleading for diagnosis. Lakartidningen, 93 (1996): 1257.
5. Backonja, M. M. Use of anticonvulsants for treatment of neuropathic pain. Neurology, 59 (5 Suppl. 2) (2002): S14-17.
6. Berger, J. R., Kumar M. Kumar A. et al. Cerebrospinal fluid dopamine in HIV-1 infection. AIDS, 8 (1994): 67-71.
7. Bottiglieri, T. Folate, vitamin B12, and neuropsychiatric disorders. Nutritional Review, 54 (1996): 382-90.
8. Breitbart, W. and Strout, D. Delirium in the mentally ill. Clinical Geriatric Medicine 16 (2) (2000): 357-72.
9. Brouillette, M.-J., Chouinard, G. and Lalonde, R. Didanosine-induced mania in HIV infection. American Journal of Psychiatry, 151 (1994): 12.
10. Busch, K. A. Psychotic states in human immunodeficiency virus illness. Current Opinion in Psychiatry, 2 (1989): 3-6.
11. Chang, L., Ernst, T., Leonido-Yee, M. et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV-1 dementia. Neurology, 53(4) (1999): 782-9.
12. Ciesla, J. A. and Roberts, J. E. Meta-analysis of the relationship between HIV-1 infection and risk for depressive disorders. American Journal of Psychiatry, 158 (2001): 725-30.
13. Cockram, A., Judd, F. K., Mijch, A. and Norman, T. The evaluation of depression in inpatients with HIV disease. Australian and New Zealand Journal of Psychiatry, 33 (1999): 344-52.
14. De la Garza, C. L. S., Paoletti-Duarte, S., Garcia-Martin, C. and Gutierrez-Casares, J. R. Efavirenzinduced psychosis. AIDS, 15(14) (2001): 1911-12.
15. De Ronchi, D., Faranca, I., Forti, P. et al. Development of acute psychotic disorders and HIV-1 infection. International Journal of Psychiatry in Medicine, 30 (2000): 173-83.
16. Dobs, A. S., Dempsey, M.A., Ladenson, P.W. and Polk, B. F. Endocrine disorders inmen infected with human immunodeficiency virus. American Journal of Medicine, 84 (1988): 611-16.
17. Dommisse, J. Subtle vitamin deficiency and psychiatry: a largely unnoticed but devastating relationship? Medical Hypothesis, 34 (1991): 131-40.
18. Ellen, S. R., Judd, F. K., Mijch, A. M. and Cockram, A. Secondary mania in patients with HIV infection. Australian and New Zealand Journal of Psychiatry, 33(3) (1999): 353-60.
19. El-Mallakh, R. S. Mania in AIDS: clinical significance and theoretical considerations. International Journal of Psychiatry in Medicine, 21(4) (1991): 383-92.
20. Evans, D. L., Ten Have, T. R., Douglas, S. D. et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV-1 infection. American Journal of Psychiatry, 159 (2002): 1752-9.
21. Fernandez, F. Neuropsychiatric aspects of human immunodeficiency virus (HIV-1) infection. Current Psychiatry Reports, 4 (2002): 228-31.
22. Fernandez, F. and Levy, J. K. Psychopharmacology in HIV-1 Spectrum disorders. Psychiatric Clinics of North America, 17 (1994): 135-48.
23. Gillenwater, D. R. and McDaniel, J. S. Rational psychopharmacology for patients with HIV-1 infection and AIDS. Psychiatric Annals, 31 (2001): 28-34.
24. Goldberger, E., Clavere, J. L. and Espagno, J. Dosage de lithium intratumoral (glioblastome cerebral). Encephale, 6 (1980): 139-44.
25. Goodkin, K., Baldewicz, T. T., Wilkie, F. L. and Tyll, M. D. Cognitive-motor impairment and disorder in HIV-1 infection. Psychiatric Annals, 31 (2001): 37-44.
26. Grant, I. and Atkinson, J. H. Neuropsychiatric aspects of HIV-1 infection and AIDS. In Kaplan and Sadock's Comprehensive Textbook of Psychiatry, 7th edn., B. J. Sadock, and V.A. Sadock, eds. pp. 308-36. Philadelphia, PA: Lippincott Williams and Wilkins, 2000.
27. Halman, M. H., Bialer, P., Wort, J. L. and Rourke, S. B. HIV-1 Disease/AIDS. In The American Psychiatric Publishing Textbook of Consultation-Liaison Psychiatry: Psychiatry in the Medically Ill, 2nd edn., M. G. Wise, and J. R. Rundell, eds. pp. 807-51. Washington, DC: American Psychiatric Publishing, Inc, 2002.
28. Halman, M. H., Worth, J. L., Sanders, K. M. et al. Anticonvulsants use in the treatment of manic syndromes in patientswith HIV-1 infection. Journal of Neuropsychiatry and Clinical Neurosciences, 5 (1993): 430-4.
29. Harris, M. J., Jeste, D. V., Gleghorn, A. and Sewell, D. D. New-onset psychosis in HIV-infected patients. Journal of Clinical Psychiatry, 53 (1991): 369-76.
30. Hugen, P. W., Burger, D. M., Brinkman, K. et al. Carbamazepine-indinavir interaction causes antiretroviral therapy failure. Annals of Pharmacotherapy, 34(4) (2000): 465-70.
31. Ickovics, J. R., Hamburger, M. E., Vlahov, D. et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-1-seropositive women: longitudinal analysis from the HIV-1 epidemiology research study. Journal of the American Medical Association, 285 (2001): 1466-74.
32. Jan Wise, M. E. Neuropsychiatric complications of nevirapine treatment. British Medical Journal, 324 (2002): 879.
33. Jover, F., Cuadrado, J. M., Andreu, L. and Merino, J. Reversible coma caused by risperidoneritonavir interaction. Clinical Neuropharmacology, 25(5) (2002): 251-3.
34. Kaplan, H. I. and Sadock, B. J. Mood Disorders, pp. 524-80. Baltimore, MD: Williams and Wilkins, (1998).
35. Kelly, D. V., Beique, L. C. and Bowme, M. I. Extrapyramidal symptoms with ritonavir/indinavir plus risperidone. Annals of Pharmacotherapy, 36(5) (2002): 827-30.
36. Lera, G. and Zirulnik, J. Pilot study with clozapine in patients with HIV-associated psychosis and drug-induced parkinsonism. Movement Disorders, 14(1)(1999): 128-31.
37. Leserman, J. HIV disease progression: depression, stress, and possible mechanisms. Biological Psychiatry, 54(3) (2003): 295-306.
38. Levin, G. M., Nelson, L. A., De Vane, C. L. et al. A pharmacokinetic drug-drug interaction study of venlafaxine and indinavir. Psychopharmacology Bulletin, 35(2) (2001): 62-71.
39. Lyketsos, C. G. and Federman, E. B. (1995). Psychiatric disorders and HIV-infection: impact on one another. Epidemiology Review, 17 (1995): 152-64.
40. Lyketsos, C. G., Schwartz, J., Fishman, M. and Treisman, G. AIDS mania. Journal of Neuropsychiatry and Clinical Neurosciences, 9(2) (1997): 277-9.
41. Maggi, J. D. and Halman, M. H. The effect of divalproex sodium on viral load: a retrospective review of HIV-1-positive patients with manic syndromes. Canadian Journal of Psychiatry, 46(4) (2001): 359-62.
42. Maldonado, J. L., Fernandez, F. and Levy, J. K. Acquired immunodeficiency syndrome. In Psychiatric Management of Neurological Disease, E. C. Lauterbach, ed. pp. 271-95. Washington, DC: American Psychiatric Publishing, Inc, 2000.
43. Markowitz, J. C., Klerman, G. L. and Perry, S. Interpersonal psychotherapy of depressed HIVseropositive outpatients. Hospital and Community Psychiatry, 43(1992): 885-90.
44. Martin, L., Tummala, R. and Fernandez, F. Psychiatric management of HIV-1 Infection and AIDS. Psychiatric Annals, 32 (2002): 133-40.
45. Maxwell, S., Scheftner, W. A., Kessler, H. A. and Busch, K. Manic syndrome associated with zidovudine treatment. Journal of the American Medical Association, 259 (1988): 3406-7.
46. McDaniel, J. S., Chung, J. Y., Brown, L. et al. Practice guideline for the treatment of patients with HIV-1/AIDS. American Journal of Psychiatry, 157 (2000): 1-61.
47. Moog, C., Kuntz-Simon, G., Caussin-Schwemling, C. and Obert, G. Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels. Journal of General Virology, 77 (1996): 1993-9.
48. Morrison, M. F., Petitto, J. M., Ten Have, T. et al. Depressive and anxiety disorders in women with HIV infection. American Journal of Psychiatry, 159 (2002): 789-96.
49. Murphy, D. A., Greenwell, L. and Hoffman, D. Factors associated with antiretroviral adherenceamong HIV-infected women with children. Abstract X14 International AIDS Conference, 2002.
50. Navia, B. A., Cho, E. S., Petito, C. K. and Price, R. W. The AIDS dementia complex: II. Neuropathology. Annals of Neurology, 19 (1986): 525-35.
51. Nemeroff, C. B., De Vane, C. L. and Pollack, B. G. Newer antidepressants and the cytochrome P450 system. American Journal of Psychiatry, 153 (1996): 311-20.
52. Poulsen, H. D. and Lublin, H. K. Efavirenz-induced psychosis leading to involuntary detention. AIDS, 17(3) (2003): 451-3.
53. Schaerf, F. W., Miller, R. R., Lipsey, J. R. and McPherson, R. W. ECT for major depression in four patients infected with human immunodeficiency virus. American Journal of Psychiatry, 146(6) (1989): 782-4.
54. Sewell, D. D., Jeste, D. V., Atkinson, J. H. et al. HIV-associated psychosis: a study of 20 cases. American Journal of Psychiatry, 151 (1994): 237-42.
55. Simpson, D. M., McArthur, J. C., Olney, R. et al. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology, 60(9) (2003): 1508-14.
56. Singh, A. N., Golledge, H. and Catalan, J. Treatment of HIV-related psychotic disorders with risperidone: a series of 21 cases. Journal of Psychosomatic Research, 42(5) (1997): 489-93.
57. Soldatovic-Stajic, B. and Drezgic-Vukic, S. Case report of a female patient with post-infection depression. Medicinski Pregled, 49 (1996): 57-8.
58. Starace, F., Bartoli, L., Aloisi, M. S. et al. Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the Neuro ICONA study. Acta Psychiatrica Scandinavica, 106(1) (2002): 20-6.
59. Tanquary, J. Lithium neurotoxicity at therapeutic levels in an AIDS patient. Journal of Nervous and Mental Disease, 181(8) (1993): 518-19.
60. Trapnell, C. B., Klecker, R. W., Jamis-Dow, C. and Collins, J. M. Glucuronidation of 3'-azido-3'-deoxythimidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid. Antimicrobial Agents and Chemotherapy, 42 (1998): 1592-6.
61. Tucker, J. S., Burnam, A., Sherbourne, C. D., Kung, F. Y. and Gifford, A. L. (2003). Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. American Journal of Medicine, 114 (2003): 573-80.
62. Wagner, G. J., Rabkin, J. G. and Rabkin, R. A comparative analysis of standard and alternative antidepressants in the treatment of human immunodeficiency virus patients. Comprehensive Psychiatry, 37 (1996): 402-8.
63. Whitefield, S. G., Everett, A. S. and Rein, M. F. Neurosyphilis and human immunodeficiency virus infection (letter). Journal of Infectious Diseases, 164 (1991): 609.
64. Wise, M. G. and Gray, K. F. Delirium, dementia, and amnestic disorders. In The American Psychiatric Press Textbook of Psychiatry, 2nd edn, R. E. Hales, S. C. Yudofsky and J. A. Talbott, eds. pp. 311-53 Washington, DC:American Psychiatric Publishing, 1994.
65. Witvrouw, M., Schmit, J. C., Van Remoortel, B. et al. Cell type-dependent effect of sodium valproate on human immunodeficiency type 1 replication in vitro. AIDS Research and Human Retroviruses, 13 (1997): 187-92.
66. American Psychiatric Association Practice Guidelines for the Treatment of Patients with HIV/AIDS. American Journal of Psychiatry, 157 (Suppl. 11)(2000).
67. Cournos, F. and Forstein, M.(eds.)What Mental Health Practitioners Need to Know about HIV and AIDS, San Francisco, CA: Jossey-Bass/Wiley, 2000.
68. Maldonado, J. L. and Fernandez, F. Neurobehavioral complications of human immunodeficiency virus infection and acquired immunodeficiency syndrome. In Neuropsychiatry, 2nd edn. R. B. Schiffer, S. M. Rao and B. S. Fogel eds. pp. 1018-33. Philadelphia, PA: Lippincott Williams and Wilkins.
69. McDaniel, J. S., Chung, J. Y., Brown, L. et al. American Psychiatric Association Practice Guideline for the Treatment of Patients with HIV/AIDS. American Journal of Psychiatry, 157 (2000): 1-61.
70. Repetto, M. J., Evans, D. L., Cruess, D. G. et al. Neuropsychopharmacologic treatment of depression and other neuropsychiatric disorders in HIV-infected individuals. CNS Spectrums, 8(1) (2003): 59-63.